GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (OTCPK:ONTTF) » Definitions » EV-to-EBIT

Oxford Nanopore Technologies (Oxford Nanopore Technologies) EV-to-EBIT : -4.80 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Oxford Nanopore Technologies's Enterprise Value is $895.7 Mil. Oxford Nanopore Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-186.6 Mil. Therefore, Oxford Nanopore Technologies's EV-to-EBIT for today is -4.80.

The historical rank and industry rank for Oxford Nanopore Technologies's EV-to-EBIT or its related term are showing as below:

ONTTF' s EV-to-EBIT Range Over the Past 10 Years
Min: -77.13   Med: -14.48   Max: -3.69
Current: -4.8

During the past 6 years, the highest EV-to-EBIT of Oxford Nanopore Technologies was -3.69. The lowest was -77.13. And the median was -14.48.

ONTTF's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Biotechnology industry
Industry Median: 10.09 vs ONTTF: -4.80

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Oxford Nanopore Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $1,944.9 Mil. Oxford Nanopore Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-186.6 Mil. Oxford Nanopore Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -9.59%.


Oxford Nanopore Technologies EV-to-EBIT Historical Data

The historical data trend for Oxford Nanopore Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies EV-to-EBIT Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - -31.14 -19.48 -10.58

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.14 - -19.48 - -10.58

Competitive Comparison of Oxford Nanopore Technologies's EV-to-EBIT

For the Biotechnology subindustry, Oxford Nanopore Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's EV-to-EBIT falls into.



Oxford Nanopore Technologies EV-to-EBIT Calculation

Oxford Nanopore Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=895.745/-186.578
=-4.80

Oxford Nanopore Technologies's current Enterprise Value is $895.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oxford Nanopore Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-186.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Nanopore Technologies  (OTCPK:ONTTF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Oxford Nanopore Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-186.578/1944.8754
=-9.59 %

Oxford Nanopore Technologies's Enterprise Value for the quarter that ended in Dec. 2023 was $1,944.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oxford Nanopore Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-186.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Nanopore Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies (Oxford Nanopore Technologies) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (Oxford Nanopore Technologies) Headlines

From GuruFocus

Oxford Nanopore Announces Technology Updates

By ACCESSWIRE ACCESSWIRE 12-02-2021

ONT releases Remora: Most Comprehensive Methylation

By ACCESSWIRE ACCESSWIRE 05-26-2022

Oxford Nanopore Releases Short Fragment Mode

By ACCESSWIRE ACCESSWIRE 03-23-2022

Oxford Nanopore Announces Tech Updates

By ACCESSWIRE ACCESSWIRE 05-20-2022

ONT Opens User Conference, Rich Science Programme

By ACCESSWIRE ACCESSWIRE 05-19-2022

ONT Chosen for Comprehensive Human Genome Program

By ACCESSWIRE ACCESSWIRE 05-13-2022

Fastest Human Genome Sequence Uses Oxford Nanopore

By ACCESSWIRE ACCESSWIRE 01-13-2022

Fastest Human Genome Sequence Uses Oxford Nanopore

By ACCESSWIRE ACCESSWIRE 01-13-2022